Anti-abortion campaign backfires.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Abstract:
      An article in Slate discusses how an anti-abortion campaign to ban the drug mifepristone has inadvertently increased its popularity. Mifepristone, often used in combination with misoprostol, was previously unknown to many women as an alternative to surgical abortions. However, after the repeal of Roe in 2022, brick-and-mortar abortion clinics closed in red states, leading women to turn to mifepristone for at-home abortions. Anti-abortion activists sued to rescind FDA approval of the drug, which gained media attention and raised awareness. As a result, the number of doctor-assisted medication abortions increased by 11 percent since 2020. [Extracted from the article]
    • Abstract:
      Copyright of Week is the property of Future Publishing Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)